EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS170-02306 
Organism
Homo sapiens 
Tissue/cell
RS4-11 
Coordinate
chr2:231304180-231305190 
TF binding sites/motifs
Number: 13             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr2:231304713-231304731GAAAGGAAAGAAGGAAGG+7.97
EWSR1-FLI1MA0149.1chr2:231304721-231304739AGAAGGAAGGAAGGAAAG+8.46
EWSR1-FLI1MA0149.1chr2:231304725-231304743GGAAGGAAGGAAAGAAAG+8.46
EWSR1-FLI1MA0149.1chr2:231304717-231304735GGAAAGAAGGAAGGAAGG+9.47
LMX1BMA0703.2chr2:231305157-231305168AATTTAATTAA+6.32
LMX1BMA0703.2chr2:231305160-231305171TTAATTAAATT-6.32
PHOX2AMA0713.1chr2:231305161-231305172TAATTAAATTA-6.62
PROP1MA0715.1chr2:231305161-231305172TAATTAAATTA+6.32
PROP1MA0715.1chr2:231305161-231305172TAATTAAATTA-6.62
Phox2bMA0681.1chr2:231305161-231305172TAATTAAATTA-6.62
SOX10MA0442.2chr2:231304292-231304303TGCTTTGTTTT-6.02
SPICMA0687.1chr2:231304559-231304573GACTTCCTGTTTTA-6.14
ZNF263MA0528.1chr2:231304722-231304743GAAGGAAGGAAGGAAAGAAAG+6.03
Number of super-enhancer constituents: 7             
IDCoordinateTissue/cell
SE_09384chr2:231304023-231305429CD14
SE_10266chr2:231304224-231307763CD19_Primary
SE_10885chr2:231272649-231341656CD20
SE_18487chr2:231303674-231309186CD4p_CD25-_Il17-_PMAstim_Th
SE_19844chr2:231304274-231307101CD4p_CD25-_Il17p_PMAstim_Th17
SE_22757chr2:231304079-231308972CD8_primiary
SE_62343chr2:231275151-231339482Tonsil
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr2231304321231304649
Number: 1             
IDChromosomeStartEnd
GH02I230439chr2231303941231304959
Enhancer Sequence
GATTTCTTTC AGCAGTGTTT TGTAGTTCTC CTCATAGAGA TCTTTCACCT CCTTGGTTAG 60
GTATATCCTA AGGTTTTTTG GATTTTTGTT GTTGTTGTTG TTGTTGTTGT TTTGCTTTGT 120
TTTTTTGGTT TATTTTTTAT TTATTTATTT TTTTGCAGCT GTTGTAAAAG GGATTTGATT 180
TGATTCTCAG CTTGATCATT GTTGGTGTAT AGCAGTGCTA CTTATGATTT TGTATCCTGA 240
AACTTAACTG AATTCATTTA TCAGATCTAT ATCTTAGGAT ACTAATCATA TCATTGGTGA 300
ACAGTGACTC AAGTTTGACT TCCTCTTTAC CGATTAGGAT GCCCTTTATT TCTTTCTTTT 360
GTCTGACTGC TCGGGCTAGG ACTTCCTGTT TTATCTTTTA CAACTCATTG TTTCCCTTGT 420
TTTATCTCTC TAAAAATGCA AACTATGTCT GCTTTTTATT TTTATTTTCA GTGTTACATA 480
AGGTTTTATA AGGTCTGATT TCACTCAATC AGTAGTTATT TTCAAATCTT TTCGAAAGGA 540
AAGAAGGAAG GAAGGAAAGA AAGACGCAGG AATATGTATA AAGGTATAGC AAACATCACA 600
CTTAATGGTG CTGCTAAGTG CTTCTTCCTT GAAATTGGAA ATAAGGCAAG GAAGTCCACT 660
CTCATCACTT CTCTTCAACA TTGTATTCAA ACTCCTAACC AGTGAAATGA GACCAAAAAA 720
TAGAAATAAT TGTTTGGAAA GAAACAGTAA GTCAGTCTAT TTGTTCATGA TATAATTATT 780
TTCTTTAAAA TACAAAGGAA ATCTATAAAT AATTTACTAG AAATACTACA TGAATTTAGC 840
AATGCCATAA ATTCATGGTT AATATGTTTC AAACCAATTA TATTTTCATA TAATAGTAAT 900
AAGGAATTTG AAAAGCATTA TCATTTAAAG TAACACCAAA ACAATAAAAT AACTAGGAAT 960
AAATTTATTA TTTTTTAAAT TTAATTAAAT TAAATTTTTT ATTTCAATAG 1010